Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: The Use of Receiver Operating Characteristic Analysis for Detection of Minimal Residual Disease Using Five-Color Multiparameter Flow Cytometry in Acute Myeloid Leukemia Identifies Patients with High Risk of Relapse
Author: Al-Mawali, A.
Gillis, D.
Lewis, I.
Citation: Cytometry Part A, 2009; 76B(2):91-101
Publisher: Wiley-Liss
Issue Date: 2009
ISSN: 1552-4949
Statement of
Adhra Al-Mawali, David Gillis and Ian Lewis
Abstract: <h4>Background</h4>Multiparameter flow cytometry (MFC) has been shown to be a useful approach for detection of minimal residual disease (MRD). The aim of the study was to determine the optimal threshold that can separate patients into two groups in terms of leukemic residual cells and relapse status after induction and consolidation chemotherapy.<h4>Methods</h4>Five-color MFC and receiver operating characteristics (ROC) analysis were used to determine the optimal threshold. This study analyzed 54 acute myeloid leukemia (AML) patients.<h4>Results</h4>LAPs were detected in 51/54 (94%) patients. MRD was evaluated in the bone marrow (BM) in morphologic complete remission from 25 and 22 patients after induction and consolidation, respectively. The threshold discriminating MRD(-) from MRD(+) cases was set at 0.15% residual leukemic cells, a level that allowed optimal sensitivity and specificity for prediction of relapse, both at postinduction (P = 0.05) and postconsolidation (P = 0.009) time points using ROC analysis. MRD level postinduction not only influenced relapse-free survival (RFS) (P = 0.004) but also overall survival (OS) (P = 0.003). Multivariate analysis showed that MRD level postinduction was a powerful independent prognostic factor for both RFS (P = 0.037) and OS (P = 0.026).<h4>Conclusions</h4>Using the ROC analysis, the threshold of 0.15% was defined as the optimal value in discriminating risk categories in AML, and postinduction MRD assessment is able to better predict disease outcome than consolidation. Therefore, MRD analysis by MFC could be used for refining the selection of therapeutic strategies and improving clinical outcome in individual patients.
Keywords: acute myeloid leukemia
multiparameter flow cytometry
minimal residual disease
leukemia associated phenotypes
receiver operating characteristics
Description: © 2008 Clinical Cytometry Society
DOI: 10.1002/cyto.b.20444
Published version:
Appears in Collections:Aurora harvest
Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.